» Authors » George Mwinnyaa

George Mwinnyaa

Explore the profile of George Mwinnyaa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jones C, Danovaro-Holliday M, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, et al.
MMWR Morb Mortal Wkly Rep . 2024 Oct; 73(43):978-984. PMID: 39480752
In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), a 10-year strategy to reduce vaccine-preventable disease (VPD)-associated morbidity and mortality. IA2030 goals include improving equitable vaccination coverage,...
2.
Hazel E, Jiwani S, Maiga A, Mady G, Wilson E, Mwinnyaa G, et al.
J Glob Health . 2024 Jun; 14:04125. PMID: 38939949
Background: Monitoring service quality for family planning programmes in low- and middle-income countries (LMICs) has been challenging due to data availability. Self-reported service quality from Demographic and Health Surveys (DHS)...
3.
Hunt J, Mwinnyaa G, Patel E, Grabowski M, Kagaayi J, H Gray R, et al.
Microbiol Spectr . 2024 Jan; 12(2):e0325323. PMID: 38189332
Rapid HIV tests are critical to HIV surveillance and universal testing and treatment programs. We assessed longitudinal patterns in indeterminate HIV rapid test results in an African population-based cohort. Prospective...
4.
Kaur G, Danovaro-Holliday M, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, et al.
MMWR Morb Mortal Wkly Rep . 2023 Oct; 72(43):1155-1161. PMID: 37883326
In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), the 2021-2030 global strategy that envisions a world where everyone, everywhere, at every age, fully benefits from vaccines....
5.
Mwinnyaa G, Peters M, Shapira G, Neill R, Sadat H, Yuma S, et al.
Vaccines (Basel) . 2023 Sep; 11(9). PMID: 37766092
Background: During and after the SARS-CoV-2 (COVID-19) pandemic, many countries experienced declines in immunization that have not fully recovered to pre-pandemic levels. This study uses routine health facility immunization data...
6.
Baral P, Ahmed T, Fernandez P, Peters M, Drouard S, Muhoza P, et al.
PLoS One . 2023 Jul; 18(7):e0288124. PMID: 37418435
Background: Vaccine hesitancy remains a critical barrier in mitigating the effects of the ongoing COVID-19 pandemic. The willingness of health care workers (HCWs) to be vaccinated, and, in turn, recommend...
7.
Ahmed T, Roberton T, Vergeer P, Hansen P, Peters M, Ofosu A, et al.
PLoS Med . 2022 Aug; 19(8):e1004070. PMID: 36040910
Background: The Coronavirus Disease 2019 (COVID-19) pandemic has had wide-reaching direct and indirect impacts on population health. In low- and middle-income countries, these impacts can halt progress toward reducing maternal...
8.
Mwinnyaa G, Hazel E, Maiga A, Amouzou A
BMC Health Serv Res . 2021 Oct; 21(Suppl 2):1083. PMID: 34689787
Background: Routinely collected health facility data usually captured and stored in Health Management Information Systems (HMIS) are potential sources of data for frequent and local disaggregated estimation of the coverage...
9.
Ogunwole S, Mwinnyaa G, Wang X, Hong X, Henderson J, Bennett W
J Am Heart Assoc . 2021 Aug; 10(17):e019612. PMID: 34398644
Background Preeclampsia increases women's risks for maternal morbidity and future cardiovascular disease. The aim of this study was to identify opportunities for prevention by examining the association between cardiometabolic risk...
10.
Mwinnyaa G, Grabowski M, H Gray R, Wawer M, Chang L, Ssekasanvu J, et al.
PLoS One . 2020 Aug; 15(8):e0237633. PMID: 32845933
Background: Indeterminate HIV test results are common, but little is known about the evolution of indeterminate serology and its sociodemographic and behavioral correlates. We assessed future HIV serological outcomes for...